Miesbach, W;
Halimeh, S;
Platokouki, H;
Podolak-Dawidziak, M;
Zdziarska, J;
Korczowski, B;
Chowdary, P;
Austin, S;
Millar, C;
Alamelu, J;
et al.
Miesbach, W; Halimeh, S; Platokouki, H; Podolak-Dawidziak, M; Zdziarska, J; Korczowski, B; Chowdary, P; Austin, S; Millar, C; Alamelu, J; Rogosch, T; Pabinger, I
(2024)
An open-label, multi-centre, post-marketing study to assess the efficacy and safety of a plasma-derived VWF/FVIII concentrate in patients with von Willebrand disease.
Haemophilia, 30 (1).
pp. 236-240.
ISSN 1365-2516
https://doi.org/10.1111/hae.14868
SGUL Authors: Austin, Steve
|
PDF
Published Version
Available under License Creative Commons Attribution Non-commercial. Download (192kB) | Preview |
Item Type: | Article | ||||||||
---|---|---|---|---|---|---|---|---|---|
Additional Information: | © 2023 The Authors. Haemophilia published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. | ||||||||
Keywords: | Humans, von Willebrand Diseases, von Willebrand Factor, Factor VIII, Patients, 1103 Clinical Sciences, Cardiovascular System & Hematology | ||||||||
SGUL Research Institute / Research Centre: | Academic Structure > Institute of Medical & Biomedical Education (IMBE) | ||||||||
Journal or Publication Title: | Haemophilia | ||||||||
ISSN: | 1365-2516 | ||||||||
Language: | eng | ||||||||
Dates: |
|
||||||||
Publisher License: | Creative Commons: Attribution-Noncommercial 4.0 | ||||||||
Projects: |
|
||||||||
PubMed ID: | 38030954 | ||||||||
Web of Science ID: | WOS:001111617700001 | ||||||||
Go to PubMed abstract | |||||||||
URI: | https://openaccess.sgul.ac.uk/id/eprint/116026 | ||||||||
Publisher's version: | https://doi.org/10.1111/hae.14868 |
Statistics
Actions (login required)
![]() |
Edit Item |